Novel marine phenazines as potential cancer chemopreventive and anti-inflammatory agents

Mar Drugs. 2012 Feb;10(2):451-464. doi: 10.3390/md10020451. Epub 2012 Feb 16.

Abstract

Two new (1 and 2) and one known phenazine derivative (lavanducyanin, 3) were isolated and identified from the fermentation broth of a marine-derived Streptomyces sp. (strain CNS284). In mammalian cell culture studies, compounds 1, 2 and 3 inhibited TNF-α-induced NFκB activity (IC₅₀ values of 4.1, 24.2, and 16.3 μM, respectively) and LPS-induced nitric oxide production (IC₅₀ values of >48.6, 15.1, and 8.0 μM, respectively). PGE₂ production was blocked with greater efficacy (IC₅₀ values of 7.5, 0.89, and 0.63 μM, respectively), possibly due to inhibition of cyclooxygenases in addition to the expression of COX-2. Treatment of cultured HL-60 cells led to dose-dependent accumulation in the subG1 compartment of the cell cycle, as a result of apoptosis. These data provide greater insight on the biological potential of phenazine derivatives, and some guidance on how various substituents may alter potential anti-inflammatory and anti-cancer effects.

Keywords: NFκB; apoptosis; chemoprevention; inflammation; lavanducyanin; phenazines.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / chemistry
  • Anti-Inflammatory Agents, Non-Steroidal / isolation & purification*
  • Anti-Inflammatory Agents, Non-Steroidal / metabolism
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Antibiotics, Antineoplastic / chemistry
  • Antibiotics, Antineoplastic / isolation & purification
  • Antibiotics, Antineoplastic / metabolism
  • Antibiotics, Antineoplastic / pharmacology
  • Anticarcinogenic Agents / chemistry
  • Anticarcinogenic Agents / isolation & purification*
  • Anticarcinogenic Agents / metabolism
  • Anticarcinogenic Agents / pharmacology*
  • Apoptosis / drug effects
  • Aquatic Organisms / metabolism*
  • Cell Line, Transformed
  • Drug Discovery
  • Fermentation
  • G1 Phase / drug effects
  • Gene Expression Regulation, Enzymologic / drug effects
  • HL-60 Cells
  • Humans
  • Inhibitory Concentration 50
  • Leukemia, Promyelocytic, Acute / drug therapy
  • Macrophages / drug effects
  • Macrophages / immunology
  • Macrophages / metabolism
  • Mice
  • Phenazines / chemistry
  • Phenazines / isolation & purification*
  • Phenazines / metabolism
  • Phenazines / pharmacology*
  • Streptomyces / metabolism*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antibiotics, Antineoplastic
  • Anticarcinogenic Agents
  • Phenazines
  • lavanducyanin